Skip to main content
$0.63 -$0.01 (-1.0%)

04:00 PM EDT on 05/26/23

Nektar Therapeutics (NASDAQ:NKTR)

CAPS Rating: 2 out of 5

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.

Current Price $0.63 Mkt Cap $119.6M
Open $0.64 P/E Ratio -0.29
Prev. Close $0.63 Div. (Yield) $0.00 (0.0%)
Daily Range $0.62 - $0.65 Volume 1,653,740
52-Wk Range $0.60 - $5.18 Avg. Daily Vol. 4,913,561

Caps

How do you think NASDAQ:NKTR will perform against the market?

Add Stock to CAPS Watchlist

All Players

242 Outperform
32 Underperform
 

All-Star Players

34 Outperform
8 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:NKTR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFBiologyFool (65.70)
Submitted September 04, 2019

Punished too much for manufacturing issues.

MarkBiotech (< 20)
Submitted January 25, 2018

many alternatives to opiods for pain which doesn't include 181. results for stand alone opdivo, keytruda for cancer melanoma, RCC are already robust. minimal benefit for 214 combo, or even arguably, no CLEAR benefit with the addition of 214. also,… More

Fools bullish on NASDAQ:NKTR are also bullish on:

Fools bearish on NASDAQ:NKTR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NKTR.

Recs

1
Member Avatar TMFBiologyFool (65.70) Submitted: 9/4/2019 12:38:42 PM : Outperform Start Price: $17.04 NASDAQ:NKTR Score: -139.50

Punished too much for manufacturing issues.

Recs

1
Member Avatar TMFBigFrog (81.45) Submitted: 12/26/2018 8:40:05 AM : Outperform Start Price: $30.77 NASDAQ:NKTR Score: -175.99

Reasonable pipeline despite near term uncertainty.

Recs

0
Member Avatar btechrisk11 (< 20) Submitted: 4/15/2018 10:28:57 PM : Outperform Start Price: $101.62 NASDAQ:NKTR Score: -156.75

NKTR took off on its oncology platform but also has an interesting opioid agonist for pain that is fast tracked because of its potential to be less addictive. this could be huge if approved.

Leaderboard

Find the members with the highest scoring picks in NKTR.

Score Leader

anticitradeshort

anticitradeshort (27.22) Score: +484.98

The Score Leader is the player with the highest score across all their picks in NKTR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
anticitradeshort 27.22 4/20/2009 Underperform NS $5.64 -88.61% +396.37% +484.98 0 Comment
lanceur 62.05 5/21/2009 Underperform 5Y $6.62 -90.30% +374.62% +464.91 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $8.15 -92.12% +303.55% +395.67 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $8.15 -92.12% +303.55% +395.67 0 Comment
shorttest4 31.06 3/8/2010 Underperform 5Y $15.07 -95.74% +267.77% +363.51 0 Comment
Finonzo < 20 8/11/2011 Underperform 5Y $5.15 -87.53% +269.88% +357.40 0 Comment
anticishort 32.14 3/30/2010 Underperform 5Y $15.39 -95.83% +257.75% +353.58 0 Comment
Bill292 27.80 12/16/2011 Underperform 5Y $5.23 -87.72% +245.60% +333.32 0 Comment
Experiment200806 < 20 6/30/2008 Underperform NS $3.45 -81.38% +238.93% +320.31 0 Comment
drakitin 99.04 8/15/2008 Underperform 1Y $5.11 -87.43% +232.62% +320.05 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NKTR.